Business Description
Applied DNA Sciences Inc
NAICS : 541380
SIC : 2835
ISIN : US03815U2015
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.01 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | -0.09 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -43.86 | |||||
Beneish M-Score | 23.27 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 27.5 | |||||
3-Year EBITDA Growth Rate | 38.3 | |||||
3-Year EPS without NRI Growth Rate | 37.1 | |||||
3-Year FCF Growth Rate | 46.3 | |||||
3-Year Book Growth Rate | -31.2 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 11.57 | |||||
9-Day RSI | 19.56 | |||||
14-Day RSI | 25.13 | |||||
6-1 Month Momentum % | -50.94 | |||||
12-1 Month Momentum % | -58.51 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.77 | |||||
Quick Ratio | 1.63 | |||||
Cash Ratio | 1.3 | |||||
Days Inventory | 23.76 | |||||
Days Sales Outstanding | 60.14 | |||||
Days Payable | 88.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -38.5 | |||||
Shareholder Yield % | -1.54 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 37.64 | |||||
Operating Margin % | -150.32 | |||||
Net Margin % | -80.14 | |||||
FCF Margin % | -84.01 | |||||
ROE % | -101.24 | |||||
ROA % | -45.73 | |||||
ROIC % | -268.12 | |||||
ROC (Joel Greenblatt) % | -508.61 | |||||
ROCE % | -106.45 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.25 | |||||
PB Ratio | 0.56 | |||||
Price-to-Tangible-Book | 1.55 | |||||
EV-to-EBIT | -0.05 | |||||
EV-to-EBITDA | -0.06 | |||||
EV-to-Revenue | 0.08 | |||||
EV-to-Forward-Revenue | 0.15 | |||||
EV-to-FCF | -0.1 | |||||
Price-to-Median-PS-Value | 0.03 | |||||
Earnings Yield (Greenblatt) % | -2000 | |||||
FCF Yield % | -254.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Applied DNA Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 8.357 | ||
EPS (TTM) (€) | -10.207 | ||
Beta | -1.21 | ||
Volatility % | 74.79 | ||
14-Day RSI | 25.13 | ||
14-Day ATR (€) | 0.171278 | ||
20-Day SMA (€) | 5.204 | ||
12-1 Month Momentum % | -58.51 | ||
52-Week Range (€) | 4.66 - 33.22 | ||
Shares Outstanding (Mil) | 0.86 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Applied DNA Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Applied DNA Sciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Applied DNA Sciences Inc Frequently Asked Questions
What is Applied DNA Sciences Inc(FRA:UDJ)'s stock price today?
When is next earnings date of Applied DNA Sciences Inc(FRA:UDJ)?
Does Applied DNA Sciences Inc(FRA:UDJ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |